Remdesivir, Tocilizumab, Baricitinib, and Favipiravir
Link to the HTAC Recommendation: HTAC Recommendations on COVID-19 Investigational Drugs Document Preview:
Dexamethasone for COVID-19
Link to the HTAC Recommendation: HTAC Recommendation on Dexamethasone Document Preview:
HTAC Guidance for Health Care Providers: COVID-19 Vaccine Gamaleya
The HTAC recommends the emergency use of Sputnik V Gam-COVID-Vac to prevent COVID-19 for persons within identified priority groups aged 18 and older. Gam-COVID-Vac under emergency use The Food and Drug Administration (FDA) issues emergency use authorization (EUA) for vaccines and drugs during public health emergencies. This authorization expedites the availability of interventions for affected continue reading : HTAC Guidance for Health Care Providers: COVID-19 Vaccine Gamaleya
HTAC Guidance for the General Public: COVID-19 Vaccine Gamaleya
The Sputnik V COVID-19 Vaccine under emergency use can reduce risk against symptomatic COVID-19 for priority groups aged 18 and older, HTAC notes in a recent recommendation Gamaleya COVID-19 Vaccine under Emergency Use The emergency use authorization of the Food and Drug Administration (FDA) (dated 19 March 2021) allows for timely access of COVID-19 vaccines continue reading : HTAC Guidance for the General Public: COVID-19 Vaccine Gamaleya